DNA vaccines for therapy of tuberculosis: Where are we now?

This publication has 52 references indexed in Scilit:

• The heat‐shock protein receptors: some answers and more questions
  Tissue Antigens, 2004
• Superinfecting mycobacteria home to established tuberculous granulomas
  Nature Immunology, 2004
• Prime-boost Vaccination based on DNA and Protein-loaded Microspheres for Tuberculosis Prevention
  Journal of Drug Targeting, 2004
• Immunotherapy with mycobacterium vaccae in the treatment of tuberculosis
  Frontiers in Bioscience-Landmark, 2004
• A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis
  Infection and Immunity, 2003
• Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis
  Gene Therapy, 2003
• Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial
  The Lancet, 2002
• Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment
  Blood, 2002
• DNA Immunization in a Mouse Model of Latent Tuberculosis: Effect of DNA Vaccination on Reactivation of Disease and on Reinfection with a Secondary Challenge
  Infection and Immunity, 2002
• Quantitative differences in interleukin-2 and interleukin-4 production by antigen-stimulated splenocytes from individually- and group-housed mice
  Life Sciences, 1994